The Flight Simulator is where every candidate intervention earns the right to touch a real patient. It combines agent-based patient simulation, virtual control arms, surrogate-endpoint detectors, and side-effect-driven unblinding modelers to surface the failure modes that have historically wasted decades of clinical effort. Using more than 110 trial-prediction models calibrated against published outcomes, sponsors can stress-test enrollment criteria, dose schedules, and biomarker strategies under realistic noise. The simulator flags concept-substitution traps — situations where a surrogate is silently swapped for the actual disease — before they reach a protocol committee. The result is faster, cheaper, more honest trial design, with documentation prepared for regulator credibility review from the first run.
Value proposition: - Catch trial failure modes before enrollment
- Virtual control arms with regulator-ready audit trails
- 110+ predictive models continuously recalibrated